Sarcoplasmic/endoplasmic reticulum calcium ATPase 2a (SERCA2a) is a target of interest in gene therapy for heart failure with reduced ejection fraction (HFrEF). However, the results of an important clinical study, the Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID) trial, were controversial. Promising results were observed in the CUPID 1 trial, but the results of the CUPID 2 trial were negative. The factors that caused the controversial results remain unclear. Importantly, enrolled patients were required to have a higher plasma level of B-type natriuretic peptide (BNP) in the CUPID 2 trial. Moreover, BNP was shown to inhibit SERCA2a expression. Therefore, it is possible that high BNP levels interact with treatment effects of SERCA2a gene transfer and accordingly lead to negative results of CUPID 2 trial. From this point of view, effects of SERCA2a gene therapy should be explored in heart failure with preserved ejection fraction, which is characterised by lower BNP levels compared with HFrEF. In this review, we summarise the current knowledge of SERCA2a gene therapy for heart failure, analyse potential interaction between BNP levels and therapeutic effects of SERCA2a gene transfer and provide directions for future research to solve the identified problems.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1136/jmedgenet-2017-105120 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Article Synopsis
- Heart failure (HF) is linked to the use of NSAIDs, but it's unclear whether they lead more to heart failure with reduced ejection fraction (HFrEF) or preserved ejection fraction (HFpEF).
- Research in mice showed that while COX-2 inhibition didn't affect cardiac function overall, aged female mice experienced signs of diastolic dysfunction and elevated BNP levels while maintaining preserved ejection fraction.
- The findings suggest that COX-2 deletion specifically leads to HFpEF rather than HFrEF and indicates that calcium handling imbalances may affect heart relaxation in this context.
Electroacupuncture alleviates acute myocardial ischemic injury in mice by regulating the β adrenergic receptor and post-receptor protein kinase A signaling pathway.
Acupunct Med
December 2024
Institute of Acupuncture and Meridian, Anhui University of Chinese Medicine, Hefei, China.
Objective: To determine the effect of electroacupuncture (EA) on β-adrenergic receptor (β-AR) and post-receptor protein kinase A (PKA) signaling pathway after acute myocardial ischemia (MI).
Methods: An MI model was established by ligating the left anterior descending coronary artery of wild-type (WT) C57/BL and β-AR mice (heterozygous for β-AR gene deletion). EA treatment was administered at HT5-HT7 or LU9-LU8.
Transcriptional changes of genes encoding sarcoplasmic reticulum calcium binding and up-taking proteins in normal and Duchenne muscular dystrophy dogs.
BMC Musculoskelet Disord
October 2024
Department of Molecular Microbiology and Immunology, School of Medicine, The University of Missouri, Columbia, MO, 65212, USA.
Article Synopsis
- Cytosolic calcium overload plays a significant role in muscle degradation in Duchenne muscular dystrophy (DMD), with the sarcoplasmic reticulum (SR) being crucial for calcium storage and regulation through the SERCA pump.
- In a study involving the canine DMD model, researchers analyzed transcriptional changes of SERCA, its regulators, and calcium-binding proteins in both skeletal muscle and heart across different disease stages, revealing distinct upregulations and downregulations.
- Results indicated that while affected dog skeletal muscle showed SERCA downregulation during the active stage, calcium-binding proteins increased at the terminal stage, with notable fiber type changes; however, minimal differences were observed in the heart and no significant sex-based expression variations were
Hypoxia-responsive zinc finger E-box-binding homeobox 2 (ZEB2) regulates a network of calcium-handling genes in the injured heart.
Cardiovasc Res
December 2024
Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Centre Utrecht (UMCU), Uppsalalaan 8, 3584 CT Utrecht, The Netherlands.
Article Synopsis
- Intracellular calcium overload contributes to heart dysfunction, and understanding how to regulate calcium levels could help develop better heart failure therapies.
- The transcription factor ZEB2, induced by HIF1α in low-oxygen conditions, helps manage genes related to calcium handling and heart contraction, thus protecting against heart issues.
- ZEB2 enhances calcium uptake by increasing phosphorylation of phospholamban, while also reducing harmful signaling that leads to heart remodeling, making it a key player in maintaining heart function.
Reassessing the Mechanisms of PLN-R14del Cardiomyopathy: From Calcium Dysregulation to S/ER Malformation.
JACC Basic Transl Sci
August 2024
Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
The phospholamban (PLN) pathogenic gene variant, p.Arg14del (PLN-R14del), can lead to dilated and arrhythmogenic cardiomyopathy, resulting in heart failure. PLN-R14del cardiomyopathy has been conceptualized as a disease caused by sarco/endoplasmic reticulum calcium adenosine triphosphatase 2a (SERCA2a) superinhibition.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!